Posts
November 26 2019
Viveve Medical Inc. announced the closing of their Underwritten offering in the amount of $10,469,997. EG&S acted as counsel to the Underwriter.
November 22 2019
IeMagin Corporation announced the closing of their At the Market offering in the amount of $1,700,000. EG&S acted as counsel to the Placement Agent.
November 22 2019
Genprex Inc. announced the closing of their Registered Direct offering in the amount of $1,267,194. EG&S acted as counsel to the Placement Agent.
November 22 2019
McEwen Mining, Inc. announced the closing of their Underwritten offering in the amount of $50,019,316. EG&S acted as counsel to the Underwriter.
November 19 2019
Yeild10 Bioscience, Inc. announced the closing of their Underwritten offering in the amount of $4,999,750. EG&S acted as counsel to the Underwriter.
November 18 2019
Lipocine Inc. announced the closing of their Registered Direct offering in the amount of $6,000,000. EG&S acted as counsel to the Placement Agent.
November 15 2019
EGS represented a family office in the sale of one of its portfolio company to a public company for $120 million in cash.
November 15 2019
Diffusion Pharmaceuticals Inc. announced the closing of their S-1 offering in the amount of $4,000,000. EG&S acted as counsel to the Placement Agent.